Literature DB >> 3600602

Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines.

A L Buller, M L Clapper, K D Tew.   

Abstract

Tumor cell resistance to alkylating agents was studied by examining Walker 256 rat mammary carcinoma cells differentially sensitive to nitrogen mustards. A resistant subpopulation (WR) was selected by exposure to chlorambucil. WR cells showed approximately a 15-fold resistance to the cytotoxic effects of nitrogen mustards and elevated glutathione S-transferase (GST) activity when compared to the sensitive parent cell line (WS). To extend these findings, the GSTs from WR and WS were purified by affinity chromatography on S-hexylglutathione coupled to epoxy-activated agarose. Substrate specificity experiments using purified GSTs demonstrated different profiles of enzyme activity for WR and WS and suggested differential isoenzyme expression in these two cell lines. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot analysis revealed that the major GST present in both WR and WS was a 26,000-Da subunit that was immunologically distinct from the rat liver GSTs. This GST subunit cross-reacted with antibodies against anionic human placental GST. In addition, three GST forms common to rat liver (29,500, 28,500 and 27,500 molecular weight) were also identified. Overexpression of the 29,500-Da protein was observed in WR cells. These data suggest that differential expression of GST subunits may contribute to the nitrogen mustard-resistant phenotype.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3600602

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  21 in total

Review 1.  Adaptive response to glutathione S-transferase inhibitors.

Authors:  P J Ciaccio; K D Tew
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 2.  Drug resistance in lung cancer.

Authors:  Manish Shanker; David Willcutts; Jack A Roth; Rajagopal Ramesh
Journal:  Lung Cancer (Auckl)       Date:  2010-05-08

3.  Expression of human glutathione S-transferases in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil.

Authors:  S M Black; J D Beggs; J D Hayes; A Bartoszek; M Muramatsu; M Sakai; C R Wolf
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

4.  Expression of recombinant glutathione S-transferase pi, Ya, or Yb1 confers resistance to alkylating agents.

Authors:  R B Puchalski; W E Fahl
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

5.  Molecular cloning and heterologous expression of a cDNA encoding a mouse glutathione S-transferase Yc subunit possessing high catalytic activity for aflatoxin B1-8,9-epoxide.

Authors:  J D Hayes; D J Judah; G E Neal; T Nguyen
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

Review 6.  Regional treatment strategies for in-transit melanoma metastasis.

Authors:  Ryan S Turley; Amanda K Raymond; Douglas S Tyler
Journal:  Surg Oncol Clin N Am       Date:  2011-01       Impact factor: 3.495

7.  Glutathione S-transferase activity of leukemic cells as a prognostic factor for response to chemotherapy in acute leukemias.

Authors:  J Koberda; A Hellmann
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

8.  Identification of placental form of glutathione S-transferase in ACNU-resistant murine glioma cell lines.

Authors:  A Hara; S Niikawa; W Zhang; N Sakai; H Yamada; N Yoshimi; H Mori
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

9.  Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis.

Authors:  Muthu Selvakumaran; Kang Shen Yao; Michael D Feldman; Peter J O'Dwyer
Journal:  Biochem Pharmacol       Date:  2007-10-11       Impact factor: 5.858

10.  Increased levels of glutathione S-transferase pi transcript as a mechanism of resistance to ethacrynic acid.

Authors:  S Kuzmich; L A Vanderveer; E S Walsh; F P LaCreta; K D Tew
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.